Books on the topic 'Gamma globulins Therapeutic use'

International Symposium on IVIG (4th 1996 Interlaken, Switzerland). Advances in intravenous immunoglobulin research and therapy: Proceedings from Interlaken's Fourth International Symposium on IVIG, 11-13 June, 1996. New York: Parthenon Pub. Group, 1996.

Weaver, James T. Calibration of gamma-ray-emitting brachytherapy sources. Gaithersburg, MD: U.S. Dept. of Commerce, National Bureau of Standards, 1988.

Dr, Huang Yung-Sheng, Mills David E, and International Symposium of GLA (1st : 1995 : San Antonio, Tex.), eds. [Gamma]-linolenic acid: Metabolism and its roles in nutrition and medicine. Champaign, Ill: AOCS Press, 1996.

United States. Congress. House. A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to immune globulins. [Washington, D.C.?]: [United States Government Printing Office], 2007.

Senate, United States Congress. A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins. Washington, D.C: U.S. G.P.O., 2008.

Lucchini, Alfio. ItaliaAlcol: Studi e ricerche in alcologia. Milano, Italy: FrancoAngeli, 2009.

Takao, Kumazawa, Kruger Lawrence, and Mizumura Kazue, eds. The polymodal receptor: A gateway to pathological pain. Amsterdam: Elsevier, 1996.

J, Garner Ronnie, and Sacher Ronald A, eds. Intravenous gammaglobulin therapy. Arlington, Va: American Association of Blood Banks, 1988.

Intravenous Immunoglobulin: Research and Therapy. Informa Healthcare, 1996.

Ballow, Mark. IVIG Therapy Today. Humana Press, 2012.

Mark, Ballow, ed. IVIG therapy today. Totowa, NJ: Humana Press, 1992.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate. Taylor & Francis Group, 2019.

Vlainic, Josipa, and Maja Jazvinscak Jembrek. Gamma-Aminobutyric Acid: Biosynthesis, Medicinal Uses and Health Effects. Nova Science Publishers, Incorporated, 2014.

1957-, Jaffe Howard S., Bucalo Louis R. 1958-, and Sherwin Stephen A. 1948-, eds. Anti-infective applications of interferon-gamma. New York: Dekker, 1992.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. Taylor & Francis Group, 2002.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. Taylor & Francis Group, 2002.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. Taylor & Francis Group, 2002.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. Taylor & Francis Group, 2002.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. Taylor & Francis Group, 2002.

Tunnicliff, Godfrey, and Christopher D. Cash. Gamma-Hydroxybutyrate: Pharmacological and Functional Aspects. CRC Press, 2002.

India. Atomic Energy Regulatory Board., ed. Safety code for telegamma therapy equipment and installations. Bombay: Atomic Energy Regulatory Board, 1986.

Godfrey, Tunnicliff, and Cash Christopher D, eds. Gamma-hydroxybutyrate: Molecular, functional, and clinical aspects. London: Taylor & Francis, 2002.

Gamma-Hydroxybutyrate: Molecular,Functional and Clinical Aspects. CRC, 2002.

Parker, Philip M. The 2007-2012 World Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics. ICON Group International, Inc., 2006.

The 2006-2011 World Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics. Icon Group International, Inc., 2005.

Parker, Philip M. The 2007-2012 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in India. ICON Group International, Inc., 2006.

Parker, Philip M. The 2007-2012 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in Japan. ICON Group International, Inc., 2006.

Parker, Philip M. The 2007-2012 Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics in the United States. ICON Group International, Inc., 2006.

ItaliaAlcol: Studi e ricerche in alcologia. Milano, Italy: FrancoAngeli, 2009.

Alfio, Lucchini, ed. ItaliaAlcol: Studi e ricerche in alcologia. Milano, Italy: FrancoAngeli, 2009.

Practical radiation safety manual. Vienna: International Atomic Energy Agency, 1992.

1931-, Tanaka Chikako, and Bowery N. G, eds. GABA: Receptors, transporters, and metabolism. Basel: Birkhäuser Verlag, 1996.

(Editor), Chikako Tanaka, and Norman G. Bowery (Editor), eds. Gaba : Receptors, Transporters and Metabolism (Advances in Pharmacological Sciences) (Advances in Pharmacological Sciences). Birkhauser, 1996.

Monti, Jaime M., Hanns Möhler, and Seithikurippu Ratnas Pandi-Perumal. GABA and Sleep: Molecular, Functional and Clinical Aspects. Springer, 2011.

Monti, Jaime M., Hanns Möhler, and Seithikurippu Ratnas Pandi-Perumal. GABA and Sleep: Molecular, Functional and Clinical Aspects. Springer, 2014.

GABA and Sleep. Springer, 2010.

Stephens, David N. Anxiolytic B-Carbolines: From Molecular Biology to the Clinic (Psychopharmacology Series). Springer-Verlag Telos, 1993.

1946-, Stephens David N., ed. Anxiolytic [Beta]-carbolines: From molecular biology to the clinic. Berlin: Springer-Verlag, 1993.

(Editor), T. Kumazawa, L. Kruger (Editor), and K. Mizumura (Editor), eds. The Polymodal Receptor - A Gateway to Pathological Pain (Progress in Brain Research). Elsevier Science, 1996.